Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana.

James MilburnOokeditse NtwayagaeRachita SureshKebatshabile NgoniCassie NorthcottJames PenneyMatthew KinsellaImogen MechieSamuel EnsorGoitseone ThamaeTshepo LeemeDavid S LawrenceTony ChebaniDaniel J GrintMark W TenfordeAva AvalosDinah RamaabyaJustus OgandoMargaret MokomaneMadisa MineJoseph N Jarvis

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

CM incidence has decreased in Botswana following expansion of ART coverage but persists at a stubbornly high incidence. Most cases are now diagnosed through the cheap and easy-to-use cryptococcal antigen test, highlighting the potential of using CM as key metric of program success in the Treat All era.

Keyphrases

quality improvement
antiretroviral therapy
hiv infected
risk factors
hiv positive
human immunodeficiency virus
hepatitis c virus
hiv aids
hiv testing
electronic health record
cerebrospinal fluid
big data
affordable care act
machine learning
human health
data analysis